Tom Hallam, Palisade Bio CEO

Pal­isade Bio is the lat­est to re­struc­ture, hun­ker­ing down on its lead pro­gram

Like so many oth­er biotechs in the bear mar­ket, Pal­isade Bio is look­ing to play the re­org game and lay off parts of its staff …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.